Orianne Wagner-Ballon - JoVE Visualize

Showing results (11-20 of 55) with videos related to

Pageof 6

Sort By:

Cytometry. Part B, Clinical Cytometry|November 7, 2017

High sensitivity of the Hematoflow™ solution for chronic myelomonocytic leukemia screeningRomain Vazquez, Mikael Roussel, Bouchra Badaoui, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006

Monocyte/macrophage dysfunctions do not impair the promotion of myelofibrosis by high levels of thrombopoietinOrianne Wagner-Ballon, Hédia Chagraoui, Eric Prina, et al.

Experimental Hematology|March 23, 2011

LYL-1 deficiency induces a stress erythropoiesisClaude Capron, Catherine Lacout, Yann Lécluse, et al.

Respiratory Research|February 1, 2007

Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in miceWilliam Raoul, Orianne Wagner-Ballon, Guitanouch Saber, et al.

American Journal of Clinical Pathology|November 2, 2018

Reference Values for WBC Differential by Hematoflow AnalysisMarion Magierowicz, Nicolas Lechevalier, Nicolas Freynet, et al.

Molecular Oncology|September 5, 2022

Evaluation of two new highly multiplexed PCR assays as an alternative to next-generation sequencing for IDH1/2 mutation detectionLoetitia Favre, Nouhoum Sako, Sihem Tarfi, et al.

Blood Cancer Journal|November 16, 2018

Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosisSihem Tarfi, Véronique Harrivel, Florent Dumezy, et al.

Blood|March 22, 2007

Proteasome inhibitor bortezomib impairs both myelofibrosis and osteosclerosis induced by high thrombopoietin levels in miceOrianne Wagner-Ballon, Didier F Pisani, Thomas Gastinne, et al.

Blood|October 15, 2010

Thrombospondin-1 is not the major activator of TGF-β1 in thrombopoietin-induced myelofibrosisSolène Evrard, Olivier Bluteau, Micheline Tulliez, et al.

Experimental Hematology|January 3, 2007

Adenoviral-mediated TGF-beta1 inhibition in a mouse model of myelofibrosis inhibit bone marrow fibrosis developmentThomas Gastinne, Frédéric Vigant, Cecile Lavenu-Bombled, et al.

Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:

Pageof 6

Cytometry. Part B, Clinical Cytometry|November 7, 2017

High sensitivity of the Hematoflow™ solution for chronic myelomonocytic leukemia screeningRomain Vazquez, Mikael Roussel, Bouchra Badaoui, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006

Monocyte/macrophage dysfunctions do not impair the promotion of myelofibrosis by high levels of thrombopoietinOrianne Wagner-Ballon, Hédia Chagraoui, Eric Prina, et al.

Experimental Hematology|March 23, 2011

LYL-1 deficiency induces a stress erythropoiesisClaude Capron, Catherine Lacout, Yann Lécluse, et al.

Respiratory Research|February 1, 2007

Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in miceWilliam Raoul, Orianne Wagner-Ballon, Guitanouch Saber, et al.

American Journal of Clinical Pathology|November 2, 2018

Reference Values for WBC Differential by Hematoflow AnalysisMarion Magierowicz, Nicolas Lechevalier, Nicolas Freynet, et al.

Molecular Oncology|September 5, 2022

Evaluation of two new highly multiplexed PCR assays as an alternative to next-generation sequencing for IDH1/2 mutation detectionLoetitia Favre, Nouhoum Sako, Sihem Tarfi, et al.

Blood Cancer Journal|November 16, 2018

Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosisSihem Tarfi, Véronique Harrivel, Florent Dumezy, et al.

Blood|March 22, 2007

Proteasome inhibitor bortezomib impairs both myelofibrosis and osteosclerosis induced by high thrombopoietin levels in miceOrianne Wagner-Ballon, Didier F Pisani, Thomas Gastinne, et al.

Blood|October 15, 2010

Thrombospondin-1 is not the major activator of TGF-β1 in thrombopoietin-induced myelofibrosisSolène Evrard, Olivier Bluteau, Micheline Tulliez, et al.

Experimental Hematology|January 3, 2007

Adenoviral-mediated TGF-beta1 inhibition in a mouse model of myelofibrosis inhibit bone marrow fibrosis developmentThomas Gastinne, Frédéric Vigant, Cecile Lavenu-Bombled, et al.

Pageof 6